Unichem Laboratories Limited operates in the Medicinals and botanicals sector. Unichem Laboratories Limited is engaged in the business of pharmaceuticals. The Company manufactures a range of formulations. The Company addresses therapeutic areas, which includes cardiac care, anti- diabetics, neuro-psychiatry, gastroenterologicals, anti- infectives, dermatology and nutraceuticals amongst others. During the fiscal year ended March 31, 2011, the Company launched 22 new brands in various therapeutic segments; four new brands were launched in cardiac care; three in Dermatology, and two in neuro- psychiatry amongst others. The Company's brand portfolio includes brands, such as Losar, Ampoxin, Trika, Olsar, TG-Tor, Unienzyme and Metride. The Company focuses on the active pharmaceutical ingredients (API) business. The Company has made 527 valid product registrations across the world and more than 300 regulatory filings. In
our complete report available for purchase the company is compared to: J.B. Chemicals & Pharmaceuticals Ltd, FDC Ltd and Elder Pharmaceuticals Ltd.